Intravitreal Injection (IVI), OPS Code 5-156.9
Conditions
Interventions
Group 1: Real treatment data of patients receiving IVI therapy will be analyzed in this study. There is no intervention as part of the study.
Sponsors
Universitätsklinikum Münster, Klinik für Augenheilkunde
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: OPS code: “5-156.9 Injection of drugs into the posterior segment of the eye”
Exclusion criteria
Exclusion criteria: < 18 years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Data from patients receiving IVI therapy is to be evaluated across all locations in order to record the actual care situation in Germany. The analyses are intended to provide information about possible risk factors and predict the course of therapy success so that treatment strategies can be more individualized in the future. The main focus will be on the medical success of the therapy. | — |
Secondary
| Measure | Time frame |
|---|---|
| Treatment latency period, Treatment and monitoring frequency, Treatment adherence, Treatment persistence | — |
Countries
Germany
Contacts
Public ContactNicole Eter
Universitätsklinikum Münster, Klinik für Augenheilkunde
Outcome results
None listed